CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Pain Measurement Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03975660
NCT03975660N/ACompleted
CompareCT.gov

Evaluation of Objective Pain Measurement Device

Stanford University·interventional·Posted Jun 5, 2019·Updated Jun 8, 2025

In Brief

A clinical study evaluating Pain Measurement Device for Pain and 2 related conditions. Completed, enrolled 130 participants across 1 site.

Detailed Summary

This study will attempt to objectively measure pain with an experimental device. The investigators will apply the device to measure patients "pain" due to uterine contractions during routine clinical care to correlate patients verbal pain ratings and analgesia requirements to that measured by the device. A brain oxygenation device, Edwards Foresight, will be used to concurrently to monitor brain oxygenation and hemodynamics, so the relationship between the CereVu ROPA device objective measure of pain and brain oxygenation/hemodynamic changes and patient-reported pain can be determined.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Analgesia, Labor Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 5, 2019
Enrollment StartNov 1, 2019
Primary CompletionOct 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 7.1 years ago

Interventions

Pain Measurement Devicedevice

When participants request labor analgesia, the sensors of the pain measurement device (ROPA System \[CereVu Medical, Inc. San Francisco, CA\] and Edwards Foresight device) will be applied to the forehead and connected to the device. Data recording is then started.